Lexicon Pharmaceuticals, Inc.
XNAS:LXRX
1.36
$1.36 - 3,318.00
$1.35 - 3,794.00
$1.34
$1.4
$1.37
$1.36
1.66
0.28
522402
1423639
184003813.06
Chart
TendieTensor AI Analysis
Company
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Fundamentals
103
-7.180000
4.113110
-0.04
100
BBG000BQ85G2
BBG001SDWCZ8
363.40M
363.40M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own LXRX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.